Shivani Pandit's Colleagues at QED Therapeutics
Sam Casillas
Head of KOL Advocacy Development, Oncology/Rare Disease Marketing & Commercialization
Shivani Pandit's Contact Details
HQ
650-231-4088
650-231-4088
Location
Company
QED Therapeutics
QED Therapeutics
Shivani Pandit's Company Details
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.
Frequently Asked Questions about Shivani Pandit
Shivani Pandit currently works for QED Therapeutics.
Shivani Pandit's role at QED Therapeutics is regulatory affairs manager.
Shivani Pandit's email address is ***@qedtx.com. To view Shivani Pandit's full email address, please signup to ConnectPlex.
Shivani Pandit works in the Biotechnology industry.
Shivani Pandit's colleagues at QED Therapeutics are Chelsea Guiseppi, Sam Casillas, Deborah Mortensen, Yvonne Stone, Roshni Khanna, Rocio Reategui, Mehrak Kiankarimi and others.
Shivani Pandit's phone number is ["+13308773664"]